Korean J Radiol.  2013 Dec;14(6):869-873. 10.3348/kjr.2013.14.6.869.

A Suspicious Breast Lesion Detected by Dynamic Contrast-Enhanced MRI and Pathologically Confirmed as Capillary Hemangioma: a Case Report and Literature Review

• Yang LH
• Ma S
• Li QC
• Xu HT
• Wang X
• Wang EH

• KMID: 1711451
• DOI: http://doi.org/10.3348/kjr.2013.14.6.869

Abstract

Breast capillary hemangioma is a type of benign vascular tumor which is rarely seen. Little is known about its presentation on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). Here, we describe a case of suspicious breast lesion detected by DCE-MRI and pathologically confirmed as capillary hemangioma. Our case indicates that a small mass with a superficial location, clear boundary, and homogeneous enhancement on DCE-MRI indicates the possible diagnosis of hemangioma, whereby even the lesion presents a washout type curve.

Keyword

Mammography; Ultrasound; Dynamic contrast-enhanced magnetic resonance imaging; Hemangioma

MeSH Terms

Adult
Biopsy
Breast Neoplasms/*diagnosis
Contrast Media/*diagnostic use
Diagnosis, Differential
Female
Hemangioma, Capillary/*diagnosis
Humans
Magnetic Resonance Imaging/*methods
Contrast Media

Figure

• 

  Fig. 1 MRI presentations of capillary hemangioma. A-F. Unenhanced T1-weighted image and T2-weighted image. DCE-MRI showed location and morphological characteristics of mass clearly. Pseudo-color picture displayed ROI (1, mass marked with red color presented high perfusion) and control region (2, mammary gland marked with black or blue color presented low perfusion), washout type curve was generated. DCE-MRI = dynamic contrast-enhanced magnetic resonance imaging. G, H. Ultrasound presents oval lesion with clear boundary and internal hypoechoic. Doppler flow imaging (CDFI) presents mass with rich blood flow signals. I-L. Highly vascularized lesion was pathologically confirmed as hemangioma (capillary type); note clear boundary and regular morphological presentation. Immunohistochemical staining showed strong positive CD34 expression and negative CK expression of vascular endothelial cells.

Reference

1. Jeh SK, Kim SH, Kang BJ. Comparison of the diagnostic performance of response evaluation criteria in solid tumor 1.0 with response evaluation criteria in solid tumor 1.1 on MRI in advanced breast cancer response evaluation to neoadjuvant chemotherapy. Korean J Radiol. 2013; 14:13–20.

2. Kang H, Lee HY, Lee KS, Kim JH. Imaging-based tumor treatment response evaluation: review of conventional, new, and emerging concepts. Korean J Radiol. 2012; 13:371–390.

3. Lyou CY, Cho N, Kim SM, Jang M, Park JS, Baek SY, et al. Computer-aided evaluation of breast MRI for the residual tumor extent and response monitoring in breast cancer patients receiving neoadjuvant chemotherapy. Korean J Radiol. 2011; 12:34–43.

4. Tilve A, Mallo R, Pérez A, Santiago P. Breast hemangiomas: correlation between imaging and pathologic findings. J Clin Ultrasound. 2012; 40:512–517.

5. Fornage BD, McGavran MH, Duvic M, Waldron CA. Imaging of the skin with 20-MHz US. Radiology. 1993; 189:69–76.

6. Siewert B, Jacobs T, Baum JK. Sonographic evaluation of subcutaneous hemangioma of the breast. AJR Am J Roentgenol. 2002; 178:1025–1027.

7. Lee SH, Cho N, Kim SJ, Cha JH, Cho KS, Ko ES, et al. Correlation between high resolution dynamic MR features and prognostic factors in breast cancer. Korean J Radiol. 2008; 9:10–18.

8. Glazebrook KN, Morton MJ, Reynolds C. Vascular tumors of the breast: mammographic, sonographic, and MRI appearances. AJR Am J Roentgenol. 2005; 184:331–338.

9. Jozefczyk MA, Rosen PP. Vascular tumors of the breast. II. Perilobular hemangiomas and hemangiomas. Am J Surg Pathol. 1985; 9:491–503.

10. Bhathal PS, Brown RW, Lesueur GC, Russell IS. Frequency of benign and malignant breast lesions in 207 consecutive autopsies in Australian women. Br J Cancer. 1985; 51:271–278.